SMMT
Price
$20.26
Change
-$0.24 (-1.17%)
Updated
Sep 25 closing price
Capitalization
15.05B
40 days until earnings call
VBIZF
Price
$0.28
Change
-$0.03 (-9.68%)
Updated
Sep 23 closing price
Capitalization
694.55M
Interact to see
Advertisement

SMMT vs VBIZF

Header iconSMMT vs VBIZF Comparison
Open Charts SMMT vs VBIZFBanner chart's image
Summit Therapeutics
Price$20.26
Change-$0.24 (-1.17%)
Volume$3.05M
Capitalization15.05B
Viva Biotech Holdings
Price$0.28
Change-$0.03 (-9.68%)
Volume$3.5K
Capitalization694.55M
SMMT vs VBIZF Comparison Chart in %
Loading...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMMT vs. VBIZF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMT is a Buy and VBIZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (SMMT: $20.26 vs. VBIZF: $0.28)
Brand notoriety: SMMT and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SMMT: 75% vs. VBIZF: 61%
Market capitalization -- SMMT: $15.05B vs. VBIZF: $694.55M
SMMT [@Biotechnology] is valued at $15.05B. VBIZF’s [@Biotechnology] market capitalization is $694.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 1 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • SMMT’s FA Score: 1 green, 4 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, both SMMT and VBIZF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMT’s TA Score shows that 5 TA indicator(s) are bullish while VBIZF’s TA Score has 5 bullish TA indicator(s).

  • SMMT’s TA Score: 5 bullish, 5 bearish.
  • VBIZF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VBIZF is a better buy in the short-term than SMMT.

Price Growth

SMMT (@Biotechnology) experienced а +5.36% price change this week, while VBIZF (@Biotechnology) price change was -9.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

SMMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($15.1B) has a higher market cap than VBIZF($695M). VBIZF has higher P/E ratio than SMMT: VBIZF (33.24) vs SMMT (26.36). VBIZF YTD gains are higher at: 295.487 vs. SMMT (13.533).
SMMTVBIZFSMMT / VBIZF
Capitalization15.1B695M2,173%
EBITDA-743.48MN/A-
Gain YTD13.533295.4875%
P/E Ratio26.3633.2479%
Revenue0N/A-
Total Cash298MN/A-
Total Debt5.55MN/A-
FUNDAMENTALS RATINGS
SMMT vs VBIZF: Fundamental Ratings
SMMT
VBIZF
OUTLOOK RATING
1..100
790
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
49100
SMR RATING
1..100
10078
PRICE GROWTH RATING
1..100
6437
P/E GROWTH RATING
1..100
855
SEASONALITY SCORE
1..100
550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VBIZF's Valuation (3) in the null industry is significantly better than the same rating for SMMT (95) in the Biotechnology industry. This means that VBIZF’s stock grew significantly faster than SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (49) in the Biotechnology industry is somewhat better than the same rating for VBIZF (100) in the null industry. This means that SMMT’s stock grew somewhat faster than VBIZF’s over the last 12 months.

VBIZF's SMR Rating (78) in the null industry is in the same range as SMMT (100) in the Biotechnology industry. This means that VBIZF’s stock grew similarly to SMMT’s over the last 12 months.

VBIZF's Price Growth Rating (37) in the null industry is in the same range as SMMT (64) in the Biotechnology industry. This means that VBIZF’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's P/E Growth Rating (8) in the Biotechnology industry is somewhat better than the same rating for VBIZF (55) in the null industry. This means that SMMT’s stock grew somewhat faster than VBIZF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMMTVBIZF
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
18%
View a ticker or compare two or three
Interact to see
Advertisement
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MVLL23.552.00
+9.28%
GraniteShares 2x Long MRVL Daily ETF
TUSI25.450.01
+0.04%
Touchstone Ultra Short Income ETF
LQDB87.64-0.14
-0.16%
iShares BBB Rated Corporate Bond ETF
EFIV62.79-0.19
-0.29%
SPDR® S&P 500® ESG ETF
RSDE21.30-0.09
-0.41%
FT Vest U.S. Eq Eql Wght Buffr ETF - Dec

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with SMMT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
SMMT - VBIZF
42%
Loosely correlated
-1.17%
AKBLF - VBIZF
24%
Poorly correlated
N/A
SPHRY - VBIZF
11%
Poorly correlated
+3.57%
WXXWY - VBIZF
5%
Poorly correlated
+1.92%
UCBJF - VBIZF
3%
Poorly correlated
-1.18%
More